Publication Distinguishing between relapse and late reversal reaction in multidrug (MDT)-treated BT leprosy. Waters M F. Leprosy review. 2001; 72 (3) : 250-3. Download PDF
Publication Is it safe to shorten multidrug therapy for lepromatous (LL and BL) leprosy to 12 months? Waters M F. Leprosy review. 1998; 69 (2) : 110-1. Download PDF
Publication Leprous neuropathies. Waters M F, Jacobs J M. Bailliere's clinical neurology. 1996; 5 (1) : 171-97.
Publication Induction of Th1 cytokine responses by mycobacterial antigens in leprosy. Dockrell H M, Young S K, Britton K, et al. Infection and immunity. 1996; 64 (10) : 4385-9. Download PDF
Publication Relapse following various types of multidrug therapy in multibacillary leprosy. Waters M F. Leprosy review. 1995; 66 (1) : 1-9. Download PDF
Publication Effect of Mycobacterium leprae in peripheral nerve trunk on the evolution of skin lesions. Ridley M J, Waters M F, Ridley D S. International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association. 1994; 62 (1) : 99-107. Download PDF
Publication Chemotherapy of leprosy--current status and future prospects. Waters M F. Transactions of the Royal Society of Tropical Medicine and Hygiene. 1993; 87 (5) : 500-3.
Publication Use of thalidomide in leprosy. Waters M F. BMJ (Clinical research ed.). 1991; 303 (6800) : 470.
Publication Possible transmission of Mycobacterium leprae in a group of UK leprosy contacts. Dockrell H M, Eastcott H, Young S, et al. Lancet (London, England). 1991; 338 (8769) : 739-43.
Publication Leprosy in reaction: a medical emergency. Malin A S, Waters M F, Shehade S A, et al. BMJ (Clinical research ed.). 1991; 302 (6788) : 1324-6.
Publication Reversal reactions in leprosy and their management. Rose P, Waters M F. Leprosy review. 1991; 62 (2) : 113-21. Download PDF
Publication Positive Mitsuda lepromin reactions in long-term treated lepromatous leprosy. Waters M F, Ridley D S, Lucas S B. Leprosy review. 1990; 61 (4) : 347-52. Download PDF
Publication Tuberculoid relapse in lepromatous leprosy. Waters M F, Ridley D S. Leprosy review. 1990; 61 (4) : 353-65. Download PDF
Publication Interpretation of published papers on controlled clinical trials. Waters M F. International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association. 1989; 57 (2) : 556-7.
Publication Events surrounding the recognition of Mycobacterium leprae in nerves. Ridley M J, Waters M F, Ridley D S. International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association. 1987; 55 (1) : 99-108.
Publication Concepts behind the development of multiple drug therapy regimens in leprosy. Waters M F. Leprosy review. 1986; Download PDF
Publication Prevalence and specificity of the enhancing effect of three types of interleukin 2 on T cell responsiveness in 97 lepromatous leprosy patients of mixed ethnic origin. Barnass S, Mace J, Steele J, et al. Clinical and experimental immunology. 1986; 64 (1) : 41-9. Download PDF
Publication The rate of relapse in lepromatous leprosy following completion of twenty years of supervised sulphone therapy. Waters M F, Rees R J, Laing A B, et al. Leprosy review. 1986; 57 (2) : 101-9. Download PDF
Publication Clinical problems in the initiation and assessment of multidrug therapy. Waters M F, Ridley D S, Ridley M J. Leprosy review. 1986; Download PDF